ISB News

NIH Research Matters Features ISB’s MTB Paper

NIH Research Matters published an article on our tuberculosis paper.

“The incredibly large number of possible drug combinations taken together with the difficulty of growing Mtb in the laboratory make discovery of effective combination therapy extremely challenging,” Dr. Nitin Baliga says. “We hope that our systems-based strategy will accelerate TB drug discovery by helping researchers prioritize combinations that are more likely to be effective.”

READ THE ARTICLE

Related Articles

  • Drs. Monica Orellana and Nitin Baliga

    New Study May Provide Knowledge for Increased Biofuel Production from Unicellular Algae

    With potential ramifications for increasing biofuel production from unicellular algae, ISB’s Drs. Mónica Orellana and Nitin Baliga, along with colleagues from the University of the Witwatersrand, used the chlorophyte algae Chlamydomonas reinhardtii to demonstrate the cell’s metabolic and physiological changes of lipid accumulation that occurs during nitrogen depletion.

    Read More
  • Path-seq illustration

    Profiling Pathogen Gene Expression from Infected Host Cells

    Researchers at ISB reported a novel method, Path-seq, to profile expression of all MTB genes within infected mice. This study presents the most comprehensive transcriptome profiling of MTB from in vivo infection and a major technical advancement for studying any host-pathogen interaction.

    Read More
  • Spotlight on Amy Zamora, ISB Systems Research Scholar

    Amy Zamora joined ISB in August as a Systems Research Scholar. The Systems Research Scholars Program provides recent college undergraduates a springboard to become the next generation’s pioneers of interdisciplinary scientific research. In this Q&A, Zamora describes her experiences at ISB, research interests, future aspirations, and much more.

    Read More
Show More Articles